Table 2.

Patient-reported outcomes at enrollment into the IPF-PRO Registry by presence of emphysema

	CPFE (n = 119)	IPF alone (n = 815)	P-value
SGRQ total score	41.8 (27.3, 53.7)	39.5 (25.1, 53.7)	0.34
SGRQ activity score	66.2 (47.6, 79.1)	54.5 (37.4, 72.8)	0.004
SGRQ impact score	26.4 (14.3, 40.0)	26.1 (14.2, 42.1)	0.96
SGRQ symptoms score	39.8 (26.2, 59.3)	44.5 (30.8, 61.7)	0.10
CASA-Q cough impact domain	87.5 (68.8, 96.9)	75.0 (56.3, 93.8)	<0.001
CASA-Q cough symptoms domain	66.7 (50.0, 83.3)	58.3 (41.7, 75.0)	<0.001
EQ-5D index score	0.8 (0.7, 0.9)	0.8 (0.7, 1.0)	0.083
EQ-5D VAS score	70.0 (60.0, 85.0)	75.0 (61.0, 85.0)	0.052
SF-12 mental component summary	53.3 (45.1, 60.2)	54.1 (45.8, 59.2)	0.92
SF-12 physical component summary	37.5 (32.2, 43.6)	39.4 (31.1, 46.6)	0.29

Data are median (25th, 75th percentile). SGRQ. St. George’s Respiratory Questionnaire. CASA-Q, Cough and Sputum Assessment Questionnaire. EQ-5D, EuroQoL 5-D index score. VAS, Visual analog scale. SF-12, Short Form-12